Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MASSNASDAQ:PRENASDAQ:QSINYSE:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMASS908 Devices$6.73-0.1%$5.94$1.81▼$8.06$241.34M0.291.05 million shs1.32 million shsPREPrenetics Global$8.49-5.7%$7.25$3.09▼$11.99$103.62M0.1722,174 shs90,202 shsQSIQuantum-Si$1.95-4.9%$1.56$0.61▼$5.77$357.82M2.8711.18 million shs12.37 million shsSENSSenseonics$0.49-1.2%$0.58$0.25▼$1.40$323.25M0.967.06 million shs6.92 million shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMASS908 Devices0.00%-8.31%+15.04%+66.58%+34.60%PREPrenetics Global0.00%-5.25%-15.10%+119.32%+38.95%QSIQuantum-Si0.00%+12.72%+14.04%+53.54%+132.47%SENSSenseonics0.00%-3.29%-7.45%-26.85%+28.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMASS908 Devices1.5279 of 5 stars1.32.00.00.02.75.00.6PREPrenetics Global1.1442 of 5 stars1.54.00.00.02.10.01.3QSIQuantum-Si2.5052 of 5 stars3.33.00.00.02.62.50.0SENSSenseonics1.7205 of 5 stars3.81.00.00.01.90.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMASS908 Devices 2.50Moderate Buy$5.33-20.75% DownsidePREPrenetics Global 3.00Buy$9.006.01% UpsideQSIQuantum-Si 2.67Moderate Buy$3.4878.21% UpsideSENSSenseonics 3.50Strong Buy$1.55213.70% UpsideCurrent Analyst Ratings BreakdownLatest PRE, SENS, QSI, and MASS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/27/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)6/11/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (D-)6/2/2025SENSSenseonicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$1.105/24/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (E+)5/19/2025QSIQuantum-SiHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.505/16/2025QSIQuantum-SiAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/10/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)4/24/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)4/10/2025SENSSenseonicsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$2.004/9/2025SENSSenseonicsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/8/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (D-)(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMASS908 Devices$59.63M4.05N/AN/A$3.29 per share2.05PREPrenetics Global$30.62M3.38N/AN/A$14.04 per share0.60QSIQuantum-Si$3.06M116.94N/AN/A$1.29 per share1.51SENSSenseonics$23.68M13.65N/AN/A$0.07 per share7.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMASS908 Devices-$72.21M-$0.54N/AN/AN/A-28.80%-27.10%-20.49%8/5/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/AQSIQuantum-Si-$101.01M-$0.68N/AN/AN/A-2,925.41%-41.44%-37.09%8/6/2025 (Estimated)SENSSenseonics-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/ALatest PRE, SENS, QSI, and MASS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 million5/15/2025Q1 2025QSIQuantum-Si-$0.17-$0.11+$0.06-$0.11$0.96 million$0.84 million5/13/2025Q1 2025MASS908 Devices-$0.27-$0.22+$0.05$1.23$11.90 million$11.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMASS908 DevicesN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/AQSIQuantum-SiN/AN/AN/AN/AN/ASENSSenseonicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMASS908 DevicesN/A7.626.97PREPrenetics GlobalN/A2.071.89QSIQuantum-SiN/A19.2418.89SENSSenseonics59.172.472.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMASS908 Devices88.06%PREPrenetics Global25.01%QSIQuantum-Si39.90%SENSSenseonics12.36%Insider OwnershipCompanyInsider OwnershipMASS908 Devices23.70%PREPrenetics Global7.80%QSIQuantum-Si30.04%SENSSenseonics4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMASS908 Devices6035.86 million27.36 millionOptionablePREPrenetics Global112.20 million11.25 millionNot OptionableQSIQuantum-Si150183.50 million128.38 millionOptionableSENSSenseonics90654.22 million573.90 millionN/APRE, SENS, QSI, and MASS HeadlinesRecent News About These CompaniesADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensorsJune 24, 2025 | medtechdive.comMSenseonics lays out hopes for next-gen CGM commercial timelinesJune 24, 2025 | drugdeliverybusiness.comDHere's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 WeeksJune 18, 2025 | zacks.comMillennium Management LLC Has $569,000 Stock Position in Senseonics Holdings, Inc. (NYSE:SENS)June 9, 2025 | marketbeat.comSenseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with DiabetesJune 4, 2025 | globenewswire.comAnalysts Offer Predictions for Senseonics FY2025 EarningsJune 4, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Senseonics Q2 Earnings?June 3, 2025 | marketbeat.comSenseonics (NYSE:SENS) Given Buy Rating at HC WainwrightJune 2, 2025 | marketbeat.comSenseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott LaboratoriesMay 21, 2025 | quiverquant.comQSenseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private PlacementMay 21, 2025 | globenewswire.comRevisiting Senseonics After 4 Years: Still A Big Investment OpportunityMay 21, 2025 | seekingalpha.comSenseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics opens $50M public offering, $25M private placement with AbbottMay 15, 2025 | drugdeliverybusiness.comDSenseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics Holdings, Inc. (AMEX:SENS) Q1 2025 Earnings Call TranscriptMay 9, 2025 | msn.comSenseonics Holdings, Inc. Reports First Quarter Financial ResultsMay 9, 2025 | finance.yahoo.comSenseonics posts Q2 sales beat, submits 365-day CGM for CE markMay 9, 2025 | drugdeliverybusiness.comDSenseonics targets $34M-$38M revenue in 2025 with Eversense 365 expansionMay 9, 2025 | msn.comSenseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comSenseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue EstimatesMay 8, 2025 | zacks.comSequel Med Tech and Senseonics Partner to Launch twiist™ AID System Compatible with Eversense® 365 CGMApril 30, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Top-Rated Energy Companies Staging Strong RecoveriesBy Nathan Reiff | June 2, 2025View 3 Top-Rated Energy Companies Staging Strong RecoveriesChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthLululemon, UNH, Enphase: Bad News, Good Opportunity?By Thomas Hughes | June 17, 2025View Lululemon, UNH, Enphase: Bad News, Good Opportunity?GitLab: Buy It Low While You Still Can—Higher Prices Are ComingBy Thomas Hughes | June 11, 2025View GitLab: Buy It Low While You Still Can—Higher Prices Are ComingPRE, SENS, QSI, and MASS Company Descriptions908 Devices NASDAQ:MASS$6.73 -0.01 (-0.15%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$7.01 +0.28 (+4.10%) As of 06/27/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Prenetics Global NASDAQ:PRE$8.49 -0.51 (-5.67%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$8.70 +0.21 (+2.41%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Quantum-Si NASDAQ:QSI$1.95 -0.10 (-4.88%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.94 -0.01 (-0.77%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.Senseonics NYSE:SENS$0.49 -0.01 (-1.18%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.50 +0.00 (+0.59%) As of 06/27/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
